Uploaded January 2019 | Updated September 2026, 1 day ago
AMMG Interviewer: Florence Comite, M.D.
Ivan Ozerov, Ph.D.
Director, Drug Discovery, Aging and Age-Related Diseases, Insilico Medicine, Inc.
Dr. Ozerov is Director, Drug Discovery, Aging and Age-related diseases, at Insilico Medicine, a Baltimore-based leader in the next-generation artificial intelligence and blockchain technologies for drug discovery, biomarker development, and aging research. Ivan graduated from Lomonosov Moscow State University in 2010 and defended his Ph.D. in radiobiology in 2015. Ivan’s Ph.D. thesis was related to kinetic modeling of the cellular pathways affected by exposure to ionizing radiation and cellular senescence. Ivan joined the international team of Insilico Medicine, Inc. in 2015 through winning the bioinformatics hackathon in Russia. Since 2015 Ivan has developed the novel state-of-the-art tool for 'omics data analysis on the level of cellular signalling pathways (iPANDA). The team led by Ivan has successfully developed and launched Young.AI, an AI-empowered platform integrating multiple biomarkers of human age in order to manage personal health, track changes overtime and optimize people's lifestyles.
What is Age Management Medicine?
Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.
About AMMG
It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical
associations and providers of products and services.
AMMG Interviewer: Florence Comite, M.D.
Ivan Ozerov, Ph.D.
Director, Drug Discovery, Aging and Age-Related Diseases, Insilico Medicine, Inc.
Dr. Ozerov is Director, Drug Discovery, Aging and Age-related diseases, at Insilico Medicine, a Baltimore-based leader in the next-generation artificial intelligence and blockchain technologies for drug discovery, biomarker development, and aging research. Ivan graduated from Lomonosov Moscow State University in 2010 and defended his Ph.D. in radiobiology in 2015. Ivan’s Ph.D. thesis was related to kinetic modeling of the cellular pathways affected by exposure to ionizing radiation and cellular senescence. Ivan joined the international team of Insilico Medicine, Inc. in 2015 through winning the bioinformatics hackathon in Russia. Since 2015 Ivan has developed the novel state-of-the-art tool for 'omics data analysis on the level of cellular signalling pathways (iPANDA). The team led by Ivan has successfully developed and launched Young.AI, an AI-empowered platform integrating multiple biomarkers of human age in order to manage personal health, track changes overtime and optimize people's lifestyles.
What is Age Management Medicine?
Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.
About AMMG
It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical
associations and providers of products and services.
